e-learning
resources
Monograph
2002
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunological mechanisms in pleural disease
V.B. Antony
Source:
Eur Respir Mon; 2002: 22: 50–59
Journal Issue:
Pleural Diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V.B. Antony. Immunological mechanisms in pleural disease. Eur Respir Mon; 2002: 22: 50–59
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Diagnosis and staging of malignant pleural mesothelioma
Related content which might interest you:
Immunological mechanisms in pleural disease
Source: Eur Respir J 2003; 21: 539-544
Year: 2003
The role of chemokines and cytokines in lung fibrosis
Source: Eur Respir Rev 2008; 17: 151-156
Year: 2008
A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma
Source: Eur Respir J 2010; 36: 1099-1105
Year: 2010
The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases
Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases
Year: 2005
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis
Source: Eur Respir J 2009; 34: 1376-1382
Year: 2009
IL-33 levels in pleural fluids from various etiologies differentially alter mesothelial cell adhesion and migration
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Source: Eur Respir J 2008; 32: 1068-1081
Year: 2008
Chemokines induced in human lung epithelial cells by inflammatory cytokines
Source: Eur Respir J 2006; 28: Suppl. 50, 748s
Year: 2006
Inflammatory response to infectious pulmonary injury
Source: Eur Respir J 2003; 22: 10S-14S
Year: 2003
Chronic inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=126
Year: 2003
Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 219-237
Year: 2022
Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion
Source: Eur Respir J 2009; 34: 184-190
Year: 2009
Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis
Source: Eur Respir J 2006; 28: 929-932
Year: 2006
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis
Source: Eur Respir J 2009; 34: 676
Year: 2009
Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease
Source: Eur Respir J 2011; 37: 1378-1385
Year: 2011
Proliferation controlling intercellular signalling pathways in human pleural malignant mesothelioma
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007
Cells and mediators of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=130
Year: 2006
Resolution of inflammation in airway diseases
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005
Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease
Source: Eur Respir J 2006 Oct 01;28(4):824-831
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept